← Evidence map

ArticleCells2023

Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.

Marilena Kampa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36831322